Skip to main content

Table 3 Discriminatory antibodies for CD8+ T cellsa

From: Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages

Discriminatory Antibody

Up(+)/Down(-)

P Value

BDL vs. NEG

  

CD57

+

0.0272

CD45RO

+

0.0307

HLA-DR

+

0.0315

CD95

+

0.0538

LTNP vs. NEG

  

HLA-DR

+

0.0039

CD11c

+

0.0072

CD38

+

0.0219

CD27 PH

-

0.0310

CD95

+

0.0545

CD57

+

0.0591

CD16

+

0.0631

CD212b1

+

0.0745

CD45RO

+

0.0953

VIR vs. NEG

  

CD57

+

0.0006

CD45RO

+

0.0067

CD38

+

0.0091

CD95

+

0.0091

HLA-DR

+

0.0190

CD9

-

0.0268

CD212b1

+

0.0776

BDL vs. LTNP

  

CD11c

-

0.0049

CD16

-

0.0093

CD56

-

0.0871

VIR vs. LTNP

  

CD11c

-

0.0017

CD56

-

0.0121

CD16

-

0.0308

CD27PH

+

0.0585

CD9

-

0.0862

VIR vs. BDL

  

CD38

+

0.0124

  1. aSix paired comparisons of CD markers on CD8+ cells providing significant discrimination between patient groups, with relative changes in CD antigen binding in the former vs. the latter denoted by "+" and "-" to indicate increase and decrease, respectively. Antigens that did not achieve statistical significance (p > 0.05) but have been previously reported in HIV disease context or have been found to be significant in other pair comparisons are also shown in italic.